BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31639484)

  • 1. Angioplasty Using Drug-Coated Balloons in Ostial Vertebral Artery Stenosis.
    Gruber P; Berberat J; Kahles T; Anon J; Diepers M; Nedeltchev K; Remonda L
    Ann Vasc Surg; 2020 Apr; 64():157-162. PubMed ID: 31639484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Device profile of different paclitaxel-coated balloons: Neuro Elutax SV, Elutax '3' Neuro and SeQuent Please NEO for the treatment of symptomatic intracranial high-grade stenosis: overview of their feasibility and safety.
    Gruber P; Remonda L
    Expert Rev Med Devices; 2020 Feb; 17(2):87-92. PubMed ID: 31962054
    [No Abstract]   [Full Text] [Related]  

  • 3. First Report of Drug-Coated Balloon Angioplasty for Vertebral Artery Origin Stenosis.
    Wang Y; Ma Y; Gao P; Chen Y; Yang B; Jiao L
    JACC Cardiovasc Interv; 2018 Mar; 11(5):500-502. PubMed ID: 29454728
    [No Abstract]   [Full Text] [Related]  

  • 4. Percutaneous transluminal angioplasty using the novel drug-coated balloon catheter SeQuent Please NEO for the treatment of symptomatic intracranial severe stenosis: feasibility and safety study.
    Gruber P; Braun C; Kahles T; Hlavica M; Anon J; Diepers M; Nedeltchev K; Berberat J; Remonda L
    J Neurointerv Surg; 2019 Jul; 11(7):719-722. PubMed ID: 30415229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
    J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of 200 Chinese Patients With Severe Femoropopliteal Lesions: 24-Month Results of AcoArt I.
    Xu Y; Jia X; Zhang J; Zhuang B; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2347-2353. PubMed ID: 30448170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial.
    Schneider PA; Laird JR; Tepe G; Brodmann M; Zeller T; Scheinert D; Metzger C; Micari A; Sachar R; Jaff MR; Wang H; Hasenbank MS; Krishnan P;
    Circ Cardiovasc Interv; 2018 Jan; 11(1):e005891. PubMed ID: 29326153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total IN.PACT drug-coated balloon initiative reporting pooled imaging and propensity-matched cohorts.
    Shishehbor MH; Schneider PA; Zeller T; Razavi MK; Laird JR; Wang H; Tieché C; Parikh SA; Iida O; Jaff MR
    J Vasc Surg; 2019 Oct; 70(4):1177-1191.e9. PubMed ID: 31543165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
    Shammas NW; Shammas GA; Jones-Miller S; Shammas WJ; Bou-Dargham B; Shammas AN; Banerjee S; Rachwan RJ; Daher GE
    Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):771-777. PubMed ID: 30420096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
    Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
    J Endovasc Ther; 2018 Feb; 25(1):109-117. PubMed ID: 29264999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic ostial vertebral artery stenosis treated with tubular coronary stents: clinical results and restenosis analysis.
    Lin YH; Juang JM; Jeng JS; Yip PK; Kao HL
    J Endovasc Ther; 2004 Dec; 11(6):719-26. PubMed ID: 15615563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of drug-coated balloon angioplasty for vertebral artery origin stenosis.
    Zhao K; Yan P; Wang X; Zhao Y; Li S; Xue Y; Liu X; Li J; Sun Q
    Neuroradiology; 2022 Aug; 64(8):1617-1625. PubMed ID: 35257205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries.
    Sixt S; Carpio Cancino OG; Treszl A; Beschorner U; Macharzina R; Rastan A; Krankenberg H; Neumann FJ; Zeller T
    J Vasc Surg; 2013 Sep; 58(3):682-6. PubMed ID: 23755977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Edge Stenosis After Covered Stenting for Long Superficial Femoral Artery Occlusive Disease: Risk Factor Analysis and Prevention With Drug-Coated Balloon Angioplasty.
    Lin TC; Huang CY; Chen PL; Lee CY; Shih CC; Chen IM
    J Endovasc Ther; 2018 Jun; 25(3):313-319. PubMed ID: 29673299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
    Steiner S; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
    JACC Cardiovasc Interv; 2018 May; 11(10):934-941. PubMed ID: 29730375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-Coated Balloon Angioplasty in Atherosclerosis Patients With Popliteal Artery Involvement.
    Dohi T; Schmidt A; Scheinert D; Bausback Y; Kabata D; Shintani A; Sakata Y; Steiner S
    J Endovasc Ther; 2018 Oct; 25(5):581-587. PubMed ID: 29986610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and meta-analysis of drug-coated balloon versus conventional balloon angioplasty for dialysis access stenosis.
    Yan Wee IJ; Yap HY; Hsien Ts'ung LT; Lee Qingwei S; Tan CS; Tang TY; Chong TT
    J Vasc Surg; 2019 Sep; 70(3):970-979.e3. PubMed ID: 31445651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
    J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
    Micari A; Vadalà G; Castriota F; Liso A; Grattoni C; Russo P; Marchese A; Pantaleo P; Roscitano G; Cesana BM; Cremonesi A
    JACC Cardiovasc Interv; 2016 May; 9(9):950-6. PubMed ID: 27151609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.